Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Network Meta-Analysis Comparing Efficacy and Safety Outcomes of Atogepant, Rimegepant, and Galcanezumab in Patients with Episodic Migraine After Including CHALLENGE-MIG Trial

Subarachnoid Hemorrhage Secondary to Borrelia burgdorferi-Associated Vasculitis: A Case Report

Prevalence of Inflammatory Bowel Disease Among Patients with MS, NMOSD, and MOGAD Attending NYU MS Care Center